Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
19.3M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
1.1M
-
Shares change
-
+108K
-
Total reported value, excl. options
-
$1.02M
-
Value change
-
+$95.7K
-
Number of buys
-
14
-
Number of sells
-
-17
-
Price
-
$0.93
Significant Holders of BIOVIE INC. - Class A Common Stock, par value $0.0001 per share (BIVI) as of Q2 2025
44 filings reported holding BIVI - BIOVIE INC. - Class A Common Stock, par value $0.0001 per share as of Q2 2025.
BIOVIE INC. - Class A Common Stock, par value $0.0001 per share (BIVI) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.1M shares
of 19.3M outstanding shares and own 5.68% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (552K shares), GEODE CAPITAL MANAGEMENT, LLC (139K shares), UBS Group AG (122K shares), JANE STREET GROUP, LLC (61.7K shares), XTX Topco Ltd (43.3K shares), SANDERS MORRIS HARRIS LLC (40K shares), TWO SIGMA SECURITIES, LLC (22.9K shares), NORTHERN TRUST CORP (20K shares), Traynor Capital Management, Inc. (18K shares), and STATE STREET CORP (16K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.